Site-specific mutations have been made in the influenza hemagglutinin
(HA) receptor binding site to assess the contribution of individual am
ino acid residues to receptor recognition. Screening of mutant HAs, ex
pressed using recombinant vaccinia virus-infected cells, for their abi
lities to bind human erythrocytes indicated that substitutions involvi
ng conserved residues Y98F, H183F, and L194A severely restricted bindi
ng and that the substitution W153A prevented cell surface expression o
f HA Mutation of residues E190 and S228 that are in positions to form
hydrogen bonds with the 9-OH of sialic acid appeared to increase eryth
rocyte binding slightly, as did the substitution G225R. Substitutions
of other residues that are directly or indirectly involved in receptor
binding, S136T, S136A, Y195F, G225D, and L226P, had intermediate effe
cts on binding between these two extremes. Estimates of changes in rec
eptor binding specificity based on inhibition of binding to erythrocyt
es by nonimmune horse sera indicated that mutants G225R and L226P, unl
ike wild-type HA, were not inhibited; Y195F and G225D mutants were, li
ke wild type, inhibited; and erythrocyte binding by mutants S136A, S13
6T, E190A, and S228G was only partially inhibited. Viruses containing
mutant HAs Y98F, S136T, G225D, and S228G that cover the range of eryth
rocyte binding properties observed were also constructed by transfecti
on. Ail four transfectant Viruses replicated in MDCK cells and embryon
ated hens' eggs as efficiently as wild-type X-31 virus, although the Y
98F mutant virus was unable to agglutinate erythrocytes. Mutant MDCK c
ells that have reduced levels of cell surface sialic acids were suscep
tible to infection by S136T, G225D, and S228G transfectant viruses and
by wild type but not by the Y98F transfectant virus. (C) 1998 Academi
c Press.